Neutrophils as active regulators of the immune system in the tumor microenvironment

Journal of Leukocyte Biology

Volumn 102, Issue 2, 2017, Pages 343-349

  Shaul, Merav E ^a   Fridlender, Zvi G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cell plasticity; Chemokines; Immunosuppressive switch; N1 N2

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE; CYTOKINE; MONOCLONAL ANTIBODY;

CANCER IMMUNOTHERAPY; CELL PLASTICITY; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MALIGNANT NEOPLASM; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED NEUTROPHIL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; CANCER STEM CELL; IMMUNOLOGY; NEOPLASM; NEUTROPHIL CHEMOTAXIS;

ANIMALS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; NEUTROPHIL INFILTRATION; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 85020819816     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5MR1216-508R     Document Type: Review

References (94)

1. Joyce, J. A., Pollard, J. W. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239–252.
2. Kerkar, S. P., Restifo, N. P. (2012) Cellular constituents of immune escape within the tumor microenvironment. Cancer Res. 72, 3125–3130.
3. Gordon, S., Martinez, F. O. (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32, 593–604.
4. Gajewski, T. F., Schreiber, H., Fu, Y. X. (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014–1022.
5. Granot, Z., Fridlender, Z. G. (2015) Plasticity beyond cancer cells and the “immunosuppressive switch.” Cancer Res. 75, 4441–4445.
6. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., Schreiber, R. D. (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991–998.
7. Kim, R., Emi, M., Tanabe, K. (2007) Cancer immunoediting from immune surveillance to immune escape. Immunology 121, 1–14.
8. Chew, V., Toh, H. C., Abastado, J. P. (2012) Immune microenvironment in tumor progression: characteristics and challenges for therapy. J. Oncol. 2012, 608406.
9. Wislez, M., Rabbe, N., Marchal, J., Milleron, B., Crestani, B., Mayaud, C., Antoine, M., Soler, P., Cadranel, J. (2003) Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 63, 1405–1412.
10. Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., von der Maase, H. (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709–4717.
11. Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., Hoffmann, T. K., Lang, S., Brandau, S. (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 129, 2183–2193.
12. Donskov, F. (2013) Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol. 23, 200–207.
13. Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q., Du, J. (2014) Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One 9, e98259.
14. Tabariès, S., Ouellet, V., Hsu, B. E., Annis, M. G., Rose, A. A., Meunier, L., Carmona, E., Tam, C. E., Mes-Masson, A. M., Siegel, P. M. (2015) Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res. 17, 45.
15. Wculek, S. K., Malanchi, I. (2015) Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528, 413–417.
16. Nozawa, H., Chiu, C., Hanahan, D. (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 103, 12493–12498.
17. Tazzyman, S., Niaz, H., Murdoch, C. (2013) Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. Semin. Cancer Biol. 23, 149–158.
18. Ishihara, Y., Fujii, T., Iijima, H., Saito, K., Matsunaga, K. (1998) The role of neutrophils as cytotoxic cells in lung metastasis: suppression of tumor cell metastasis by a biological response modifier (PSK). In Vivo 12, 175–182.
19. Granot, Z., Henke, E., Comen, E. A., King, T. A., Norton, L., Benezra, R. (2011) Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20, 300–314.
20. López-Lago, M. A., Posner, S., Thodima, V. J., Molina, A. M., Motzer, R. J., Chaganti, R. S. (2013) Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32, 1752–1760.
21. Granot, Z., Jablonska, J. (2015) Distinct functions of neutrophil in cancer and its regulation. Mediators Inflamm. 2015, 701067.
22. Sionov, R. V., Fridlender, Z. G., Granot, Z. (2015) The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 8, 125–158.
23. Coffelt, S. B., Wellenstein, M. D., de Visser, K. E. (2016) Neutrophils in cancer: neutral no more. Nat. Rev. Cancer 16, 431–446.
24. Treffers, L. W., Hiemstra, I. H., Kuijpers, T. W., van den Berg, T. K., Matlung, H. L. (2016) Neutrophils in cancer. Immunol. Rev. 273, 312–328.
25. Wynn, T. A., Chawla, A., Pollard, J. W. (2013) Macrophage biology in development, homeostasis and disease. Nature 496, 445–455.
26. Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., Albelda, S. M. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell 16, 183–194.
27. Andzinski, L., Kasnitz, N., Stahnke, S., Wu, C. F., Gereke, M., von Köckritz-Blickwede, M., Schilling, B., Brandau, S., Weiss, S., Jablonska, J. (2016) Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int. J. Cancer 138, 1982–1993.
28. Shaul, M. E., Levy, L., Sun, J., Mishalian, I., Singhal, S., Kapoor, V., Horng, W., Fridlender, G., Albelda, S. M., Fridlender, Z. G. (2016) Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs. OncoImmunology 5, e1232221.
29. Uchida, T., Yamashita, T., Araki, A., Watanabe, H., Sendo, F. (1997) rIFN-gamma-activated rat neutrophils induce tumor cell apoptosis by nitric oxide. Int. J. Cancer 71, 231–236.
30. Sparmann, A., Bar-Sagi, D. (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447–458.
31. Kobayashi, Y. (2008) The role of chemokines in neutrophil biology. Front. Biosci. 13, 2400–2407.
32. Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., Fridlender, Z. G. (2013) Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 62, 1745–1756.
33. Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., Conejo-Garcia, J. R., Feldman, M., Albelda, S. M., Singhal, S. (2014) Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 124, 5466–5480.
34. Kim, J., Bae, J. S. (2016) Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016, 6058147.
35. Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., Albelda, S. M. (2012) Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One 7, e31524.
36. Sagiv, J. Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., Damti, P., Lumbroso, D., Polyansky, L., Sionov, R. V., Ariel, A., Hovav, A. H., Henke, E., Fridlender, Z. G., Granot, Z. (2015) Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Reports 10, 562–573.
37. Ostrand-Rosenberg, S. (2010) Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol. Immunother. 59, 1593–1600.
38. Zilio, S., Serafini, P. (2016) Neutrophils and granulocytic MDSC: the Janus god of cancer immunotherapy. Vaccines (Basel) 4, E31.
39. hi suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179, 5228–5237.
40. Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., Albina, J. E. (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64–70.
41. Sevko, A., Umansky, V. (2013) Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves. J. Cancer 4, 3–11.
42. Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., Segal, D. M. (2002) Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168, 689–695.
43. Mishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S. M., Granot, Z., Fridlender, Z. G. (2014) Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17-a new mechanism of impaired antitumor immunity. Int. J. Cancer 135, 1178–1186.
44. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23–35.
45. Cavnar, M. J., Zeng, S., Kim, T. S., Sorenson, E. C., Ocuin, L. M., Balachandran, V. P., Seifert, A. M., Greer, J. B., Popow, R., Crawley, M. H., Cohen, N. A., Green, B. L., Rossi, F., Besmer, P., Antonescu, C. R., DeMatteo, R. P. (2013) KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J. Exp. Med. 210, 2873–2886.
46. Mantovani, A., Schioppa, T., Porta, C., Allavena, P., Sica, A. (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 25, 315–322.
47. Tourkova, I. L., Shurin, G. V., Ferrone, S., Shurin, M. R. (2009) Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells. Cancer Immunol. Immunother. 58, 567–574.
48. Ma, Y., Shurin, G. V., Peiyuan, Z., Shurin, M. R. (2013) Dendritic cells in the cancer microenvironment. J. Cancer 4, 36–44.
49. Tran Janco, J. M., Lamichhane, P., Karyampudi, L., Knutson, K. L. (2015) Tumor-infiltrating dendritic cells in cancer pathogenesis. J. Immunol. 194, 2985–2991.
50. Cremer, I., Fridman, W. H., Sautès-Fridman, C. (2012) Tumor microenvironment in NSCLC suppresses NK cells function. OncoImmunology 1, 244–246.
51. Joyce, J. A., Fearon, D. T. (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74–80.
52. + regulatory T cells. J. Immunol. 177, 896–904.
53. Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., De Palma, A., Mauri, P., Monegal, A., Rescigno, M., Savino, B., Colombo, P., Jonjic, N., Pecanic, S., Lazzarato, L., Fruttero, R., Gasco, A., Bronte, V., Viola, A. (2011) Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J. Exp. Med. 208, 1949–1962.
54. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., Lennon, V. A., Celis, E., Chen, L. (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793–800.
55. Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., David, O., Burow, M., Gordon, A., Dhurandhar, N., Myers, L., Berggren, R., Hemminki, A., Alvarez, R. D., Emilie, D., Curiel, D. T., Chen, L., Zou, W. (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9, 562–567.
56. Salmon, H., Donnadieu, E. (2012) Within tumors, interactions between T cells and tumor cells are impeded by the extracellular matrix. OncoImmunology 1, 992–994.
57. Salmon, H., Franciszkiewicz, K., Damotte, D., Dieu-Nosjean, M. C., Validire, P., Trautmann, A., Mami-Chouaib, F., Donnadieu, E. (2012) Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Invest. 122, 899–910.
58. Munn, D. H., Mellor, A. L. (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 34, 137–143.
59. Hadrup, S., Donia, M., Thor Straten, P. (2013) Effector CD4 and CD8 T cells and their role in the tumor microenvironment. Cancer Microenviron. 6, 123–133.
60. Benevides, L., da Fonseca, D. M., Donate, P. B., Tiezzi, D. G., De Carvalho, D. D., de Andrade, J. M., Martins, G. A., Silva, J. S. (2015) IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Res. 75, 3788–3799.
61. Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C. S., Verstegen, N. J., Ciampricotti, M., Hawinkels, L. J., Jonkers, J., de Visser, K. E. (2015) IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348.
62. Wu, P., Wu, D., Ni, C., Ye, J., Chen, W., Hu, G., Wang, Z., Wang, C., Zhang, Z., Xia, W., Chen, Z., Wang, K., Zhang, T., Xu, J., Han, Y., Zhang, T., Wu, X., Wang, J., Gong, W., Zheng, S., Qiu, F., Yan, J., Huang, J. (2014) γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40, 785–800.
63. Scapini, P., Lapinet-Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., Cassatella, M. A. (2000) The neutrophil as a cellular source of chemokines. Immunol. Rev. 177, 195–203.
64. Medina-Echeverz, J., Fioravanti, J., Zabala, M., Ardaiz, N., Prieto, J., Berraondo, P. (2011) Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells. J. Immunol. 186, 807–815.
65. Spiegel, A., Brooks, M. W., Houshyar, S., Reinhardt, F., Ardolino, M., Fessler, E., Chen, M. B., Krall, J. A., DeCock, J., Zervantonakis, I. K., Iannello, A., Iwamoto, Y., Cortez-Retamozo, V., Kamm, R. D., Pittet, M. J., Raulet, D. H., Weinberg, R. A. (2016) Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov. 6, 630–649.
66. Lefkowitz, D. L., Lefkowitz, S. S. (2001) Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited. Immunol. Cell Biol. 79, 502–506.
67. Droeser, R. A., Hirt, C., Eppenberger-Castori, S., Zlobec, I., Viehl, C. T., Frey, D. M., Nebiker, C. A., Rosso, R., Zuber, M., Amicarella, F., Iezzi, G., Sconocchia, G., Heberer, M., Lugli, A., Tornillo, L., Oertli, D., Terracciano, L., Spagnoli, G. C. (2013) High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One 8, e64814.
68. Rymaszewski, A. L., Tate, E., Yimbesalu, J. P., Gelman, A. E., Jarzembowski, J. A., Zhang, H., Pritchard, K. A., Jr., Vikis, H. G. (2014) The role of neutrophil myeloperoxidase in models of lung tumor development. Cancers (Basel) 6, 1111–1127.
69. Fossati, G., Ricevuti, G., Edwards, S. W., Walker, C., Dalton, A., Rossi, M. L. (1999) Neutrophil infiltration into human gliomas. Acta Neuropathol. 98, 349–354.
70. Reid, M. D., Basturk, O., Thirabanjasak, D., Hruban, R. H., Klimstra, D. S., Bagci, P., Altinel, D., Adsay, V. (2011) Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod. Pathol. 24, 1612–1619.
71. Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., Inferrera, C. (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod. Pathol. 15, 831–837.
72. Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I. J., Larsen, S., Gehl, J., von der Maase, H. (2005) Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br. J. Cancer 93, 273–278.
73. Lechner, M. G., Liebertz, D. J., Epstein, A. L. (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185, 2273–2284.
74. Rotondo, R., Barisione, G., Mastracci, L., Grossi, F., Orengo, A. M., Costa, R., Truini, M., Fabbi, M., Ferrini, S., Barbieri, O. (2009) IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int. J. Cancer 125, 887–893.
75. Singhal, S., Bhojnagarwala, P. S., O’Brien, S., Moon, E. K., Garfall, A. L., Rao, A. S., Quatromoni, J. G., Stephen, T. L., Litzky, L., Deshpande, C., Feldman, M. D., Hancock, W. W., Conejo-Garcia, J. R., Albelda, S. M., Eruslanov, E. B. (2016) Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell 30, 120–135.
76. Demers, M., Krause, D. S., Schatzberg, D., Martinod, K., Voorhees, J. R., Fuchs, T. A., Scadden, D. T., Wagner, D. D. (2012) Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc. Natl. Acad. Sci. USA 109, 13076–13081.
77. Berger-Achituv, S., Brinkmann, V., Abed, U. A., Kühn, L. I., Ben-Ezra, J., Elhasid, R., Zychlinsky, A. (2013) A proposed role for neutrophil extracellular traps in cancer immunoediting. Front. Immunol. 4, 48.
78. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., Zychlinsky, A. (2004) Neutrophil extracellular traps kill bacteria. Science 303, 1532–1535.
79. Yipp, B. G., Kubes, P. (2013) NETosis: how vital is it? Blood 122, 2784–2794.
80. Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., Zychlinsky, A. (2007) Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231–241.
81. Metzler, K. D., Fuchs, T. A., Nauseef, W. M., Reumaux, D., Roesler, J., Schulze, I., Wahn, V., Papayannopoulos, V., Zychlinsky, A. (2011) Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117, 953–959.
82. Papayannopoulos, V., Metzler, K. D., Hakkim, A., Zychlinsky, A. (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677–691.
83. Tillack, K., Breiden, P., Martin, R., Sospedra, M. (2012) T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J. Immunol. 188, 3150–3159.
84. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., Bassett, R., Amuro, H., Fukuhara, S., Ito, T., Liu, Y. J., Gilliet, M. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19.
85. Barrientos, L., Bignon, A., Gueguen, C., de Chaisemartin, L., Gorges, R., Sandré, C., Mascarell, L., Balabanian, K., Kerdine-Römer, S., Pallardy, M., Marin-Esteban, V., Chollet-Martin, S. (2014) Neutrophil extracellular traps downregulate lipopolysaccharide-induced activation of monocyte-derived dendritic cells. J. Immunol. 193, 5689–5698.
86. Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., Ferri, L. (2013) Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. 123, 3446–3458.
87. Demers, M., Wagner, D. D. (2014) NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin. Thromb. Hemost. 40, 277–283.
88. Bierie, B., Moses, H. L. (2010) Transforming growth factor beta (TGF-β) and inflammation in cancer. Cytokine Growth Factor Rev. 21, 49–59.
89. Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., de Gramont, A. (2015) Targeting the TGFβ pathway for cancer therapy. Pharmacol. Ther. 147, 22–31.
90. Reibman, J., Meixler, S., Lee, T. C., Gold, L. I., Cronstein, B. N., Haines, K. A., Kolasinski, S. L., Weissmann, G. (1991) Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc. Natl. Acad. Sci. USA 88, 6805–6809.
91. Pico de Coaña, Y., Poschke, I., Gentilcore, G., Mao, Y., Nyström, M., Hansson, J., Masucci, G. V., Kiessling, R. (2013) Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their arginase1 production. Cancer Immunol. Res. 1, 158–162.
92. De Kleijn, S., Langereis, J. D., Leentjens, J., Kox, M., Netea, M. G., Koenderman, L., Ferwerda, G., Pickkers, P., Hermans, P. W. (2013) IFN-γ-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. PLoS One 8, e72249.
93. McNab, F. W., Berry, M. P., Graham, C. M., Bloch, S. A., Oni, T., Wilkinson, K. A., Wilkinson, R. J., Kon, O. M., Banchereau, J., Chaussabel, D., O’Garra, A. (2011) Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur. J. Immunol. 41, 1941–1947.
94. He, G., Zhang, H., Zhou, J., Wang, B., Chen, Y., Kong, Y., Xie, X., Wang, X., Fei, R., Wei, L., Chen, H., Zeng, H. (2015) Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 34, 141.